The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer

被引：41

作者：

Klos, Patrycja ^{[1
]}

Dabravolski, Siarhei A. ^{[2
]}

机构：

[1] Pomeranian Med Univ, Dept Biochem & Med Chem, 72 Al Powstancow Wlkp, PL-70111 Szczecin, Poland

[2] Vitebsk State Acad Vet Med UO VGAVM, Dept Clin Diagnost, 7-11 Dovatora Str, Vitebsk 210026, BELARUS

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 21期

关键词：

inflammatory bowel diseases; colorectal cancer; chronic inflammation; mitochondrial dysfunction; mitochondrial mutations; D-LOOP REGION; DIFFERENTIAL EXPRESSION; CLINICAL-SIGNIFICANCE; RISK; POLYMORPHISMS; PATHOGENESIS; PGC-1-ALPHA; CHAPERONE; CELLS; DNA;

D O I：

10.3390/ijms222111673

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Inflammatory bowel disease (IBD) is one of the leading gut chronic inflammation disorders, especially prevalent in Western countries. Recent research suggests that mitochondria play a crucial role in IBD development and progression to the more severe disease-colorectal cancer (CRC). In this review, we focus on the role of mitochondrial mutations and dysfunctions in IBD and CRC. In addition, main mitochondria-related molecular pathways involved in IBD to CRC transition are discussed. Additionally, recent publications dedicated to mitochondria-targeted therapeutic approaches to cure IBD and prevent CRC progression are discussed.

引用

页数：19

共 120 条

[101] Mitogenomic differences between the normal and tumor cells of colorectal cancer patients [J].